Results 61 to 70 of about 48,268 (218)

Acyclovir Nephrotoxicity: A Case Report Highlighting the Importance of Prevention, Detection, and Treatment of Acyclovir-Induced Nephropathy

open access: yesCase Reports in Medicine, 2010
Acute kidney injury is an unfortunate complication of acyclovir therapy secondary to crystal-induced nephropathy. It is characterized by a decrease in renal function that develops within 24–48 hours of acyclovir administration indicated by a rapid rise ...
Raymond Fleischer, Michael Johnson
doaj   +1 more source

Two cases of fungal keratitis caused by Metarhizium anisopliae [PDF]

open access: yes, 2018
We present two cases of keratitis due to Metarhizium anisopliae in geographically separated areas of the United States. The isolates were microscopically similar but morphologically different and were identified by ribosomal DNA sequencing. Both isolates
Burd, Eileen M   +5 more
core   +2 more sources

The safe and effective use of tofacitinib and ustekinumab combination therapy in infantile onset inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Infantile‐onset inflammatory bowel disease (IOIBD) is a rare and severe subset of very‐early‐onset IBD, often associated with immune dysregulation and poor response to conventional therapies. Data regarding the use of Janus kinase inhibitors (JAKI) in this population is limited.
Smridhi Mahajan   +2 more
wiley   +1 more source

A case of atypical disseminated herpes simplex virus 1 with hepatitis in a liver transplant recipient: the need for dermatologic evaluation [PDF]

open access: yes, 2020
Disseminated herpes simplex virus (HSV) is mainly seen in immunocompromised individuals. Atypical lesions can be present in both primary infection and reactivation disease. Compared with the general population, inmunocompromised hosts are at greater risk
Bea-Ardebol, S   +5 more
core  

A Comparative Study to Evaluate the Efficacy and Safety of Acyclovir and Famciclovir in the Management of Herpes Zoster [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2013
Background: Over the years, acyclovir has been the oral antiviral agent approved for the treatment of patients with acute herpes zoster,Its effectiveness in lessening the acute signs and symptoms of herpes zoster has been established but the effects ...
M.G. GOPAL   +5 more
doaj   +1 more source

Interventions for preventing oral mucositis for patients with cancer receiving treatment [PDF]

open access: yes, 2003
Background: Treatment of cancer with chemotherapy is becoming increasingly more effective but is associated with short and long-term side effects. Oral side effects remain a major source of illness despite the use of a variety of agents to prevent them ...
Bryan, Gemma   +8 more
core   +3 more sources

The effects of oral Acyclovir in the treatment of necrotizing Herpetic keratouveitis [PDF]

open access: yesActa Medica Iranica, 2000
This study was conducted to evaluate the effects of administering oral acyclovir in conjunction with topical acyclovir and steroids in the treatment of necrotizing herpetic keratouveitis.
"Hosseini Tehrani M;Poormostadam B;Vallaei N;Raiszadeh F "
doaj   +1 more source

The use of nerve growth factor in herpetic keratitis: a case report

open access: yesJournal of Medical Case Reports, 2007
Background We evaluate the role of nerve growth factor (NGF) eye drops to treat a herpetic corneal ulcer resistant to systemic and local acyclovir treatment in an HIV-positive patient.
Cellini Mauro   +2 more
doaj   +1 more source

Improvement of physicochemical parameters of acyclovir using cocrystallization approach

open access: yesBrazilian Journal of Pharmaceutical Sciences
Acyclovir is an antiviral drug having potent activity against the virus of herpes family and varicella zoster. Unfortunately, drug suffers very poor oral bioavailability (15-30%).
Jignasa Ketan Savjani, Chirag Pathak
doaj   +1 more source

Intestinal transplantation [PDF]

open access: yes, 1994
Intestinal transplantation is often the only alternative form of treatment for patients dependent on total parenteral nutrition for survival.
Andreas G. Tzakis, M.D   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy